Endocrinology
News, opinions and meeting coverage in endocrinology.
Latest in Endocrinology
Ethics disclosures reveal a list of stock and bond trades made on Trump's behalf
Significantly higher pCR rate, better PFS linked to diet-associated reductions in insulin
Accumulating evidence of possible benefit warrants randomized trials, experts say
GLP-1 agonists not helpful, may be harmful whereas neural, topical strategies often useful
Accumulating evidence of possible benefit warrants randomized trials, experts say
GLP-1 agonists not helpful, may be harmful whereas neural, topical strategies often useful
Endocrinology Case Studies
Surgery may not always be the best option, case report finds
Diagnosis of this rare disease is often a challenge
Case authors report an unexpected paradoxical effect
More in Endocrinology
Children's Hospital Colorado suspended treatments for transgender kids in January
Adding tirzepatide helped patients shed pounds, improved complete skin clearance rates
Move comes as part of Texas Children's Hospital settlement with Texas, Trump administration
DOJ demanded Rhode Island Hospital hand over birth dates, Social Security numbers, and addresses
Resolution occurred after stopping dulaglutide, no obvious clues to mechanism
Other hospitals may also have received subpoenas as part of a federal criminal investigation
Appeal will be limited because the rule doesn't help employers pay for the benefit
Lower mortality seen in observational study, but experts cast doubt on underlying data
No overall change in retinal thickening with tonabersat but thicker retinas appeared to benefit
Two patients lost weight and reduced insulin burden without safety concerns
Adding vamikibart to VEGF inhibition improved visual acuity and retinal anatomy
Despite increasing use, evidence on the effects of GLP-1 drugs around pregnancy is limited
Findings come amid growing off-label prescribing of GLP-1 drugs for addiction
Better diabetes medications, better screening, older age at onset of DRD influence 20-year trend
Black women more likely to receive off-label meds; Asian women more apt to get no pharma at all
Findings could help in counseling patients and setting expectations, researchers say
Small internal tears in Omnipod 5 insulin pump pods could lead to underdosing
Agency proposal would exclude semaglutide, tirzepatide, and liraglutide from 503B bulks list
Patients should not stop using recalled True Metrix systems until a replacement is ready
Findings have implications for treating neuropsychiatric disorders involving reward dysfunction
People with prediabetes and certain genetic profiles may benefit from high-dose supplementation













